These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16532014)

  • 41. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
    Valcárcel D; Martino R
    Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Which factors determine our quality of life, health and ability? Results from a Danish population sample and the Copenhagen perinatal cohort.
    Ventegodt S; Flensborg-Madsen T; Andersen NJ; Merrick J
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):445-50. PubMed ID: 18760073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation.
    Kim DH; Sohn SK; Won DI; Lee NY; Suh JS; Lee KB
    Bone Marrow Transplant; 2006 Jun; 37(12):1119-28. PubMed ID: 16699530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
    Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):235-44. PubMed ID: 17241929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls.
    Bishop MM; Beaumont JL; Hahn EA; Cella D; Andrykowski MA; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
    J Clin Oncol; 2007 Apr; 25(11):1403-11. PubMed ID: 17416860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
    Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation.
    El-Jawahri AR; Traeger LN; Kuzmuk K; Eusebio JR; Vandusen HB; Shin JA; Keenan T; Gallagher ER; Greer JA; Pirl WF; Jackson VA; Ballen KK; Spitzer TR; Graubert TA; McAfee SL; Dey BR; Chen YB; Temel JS
    Cancer; 2015 Mar; 121(6):951-9. PubMed ID: 25469752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Routine screening for psychosocial distress following hematopoietic stem cell transplantation.
    Lee SJ; Loberiza FR; Antin JH; Kirkpatrick T; Prokop L; Alyea EP; Cutler C; Ho VT; Richardson PG; Schlossman RL; Fisher DC; Logan B; Soiffer RJ
    Bone Marrow Transplant; 2005 Jan; 35(1):77-83. PubMed ID: 15502851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
    Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
    Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS?
    El-Jawahri A; Kim HT; Steensma DP; Cronin AM; Stone RM; Watts CD; Chen YB; Cutler CS; Soiffer RJ; Abel GA
    Bone Marrow Transplant; 2016 Aug; 51(8):1121-6. PubMed ID: 26999469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study.
    Devins GM; Mah K; Messner HA; Xenocostas A; Gauvin L; Lipton JH
    Support Care Cancer; 2018 Jul; 26(7):2379-2386. PubMed ID: 29423678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients.
    Hamilton BK; Law AD; Rybicki L; Abounader D; Dabney J; Dean R; Duong HK; Gerds AT; Hanna R; Hill BT; Jagadeesh D; Kalaycio ME; Lawrence C; McLellan L; Pohlman B; Sobecks RM; Bolwell BJ; Majhail NS
    Bone Marrow Transplant; 2015 Sep; 50(9):1235-40. PubMed ID: 26030045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical factors associated with fatigue in haematologic cancer patients receiving stem-cell transplantation.
    Prieto JM; Blanch J; Atala J; Carreras E; Rovira M; Cirera E; Gastó C
    Eur J Cancer; 2006 Aug; 42(12):1749-55. PubMed ID: 16314087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of early quality of life outcomes in autologous and allogeneic transplant patients.
    Garcia CM; Mumby PB; Thilges S; Stiff PJ
    Bone Marrow Transplant; 2012 Dec; 47(12):1577-82. PubMed ID: 22562082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients.
    Jamani K; Onstad LE; Bar M; Carpenter PA; Krakow EF; Salit RB; Flowers MED; Lee SJ
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2271-2276. PubMed ID: 29935213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term health status and quality of life outcomes of lung transplant recipients.
    Gross CR; Savik K; Bolman RM; Hertz MI
    Chest; 1995 Dec; 108(6):1587-93. PubMed ID: 7497766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in nutritional status, body composition, quality of life, and physical activity levels of cancer patients undergoing autologous peripheral blood stem cell transplantation.
    Hung YC; Bauer J; Horsley P; Waterhouse M; Bashford J; Isenring E
    Support Care Cancer; 2013 Jun; 21(6):1579-86. PubMed ID: 23306934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patient education in allogeneic hematopoietic cell transplant: what patients wish they had known about quality of life.
    Jim HS; Quinn GP; Gwede CK; Cases MG; Barata A; Cessna J; Christie J; Gonzalez L; Koskan A; Pidala J
    Bone Marrow Transplant; 2014 Feb; 49(2):299-303. PubMed ID: 24121210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circadian Rhythmicity as a Predictor of Quality of Life in Allogeneic Hematopoietic Cell Transplant Patients.
    Hoogland AI; Bulls HW; Gonzalez BD; Small BJ; Liu L; Pidala J; Jim HSL; Mishra A
    J Pain Symptom Manage; 2019 May; 57(5):952-960.e1. PubMed ID: 30711631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.